Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab therapy for the type B syndrome of severe insulin resistance.

Literature DB >> 14724317

Rituximab therapy for the type B syndrome of severe insulin resistance.

Anthony P Coll, Stephen Thomas, Ghulam J Mufti.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2004 PMID： 14724317 DOI： 10.1056/NEJM200401153500324

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Paradigm shift in the management of type B insulin resistance.

Authors: Jun Hwa Hong; Hyun Jin Kim; Kang Seo Park; Bon Jeong Ku
Journal: Ann Transl Med Date: 2018-12

2. Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.

Authors: Pierre Arnautou; Martine Auclair; Soraya Fellahi; Clara Bouché; Claire Fieschi; Elias Barrak; Viviane Queyrel-Moranne; Lucy Chaillous; Nicolas Blin; Marion Malphettes; Jehane Fadlallah; Remi Bertinchamp; Laurence Gérard; Djaouida Bengoufa; Lionel Galicier; Eric Oksenhendler; Corinne Vigouroux; David Boutboul
Journal: Blood Adv Date: 2021-04-13

3. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Authors: R Malek; A Y Chong; B C Lupsa; A O Lungu; E K Cochran; M A Soos; R K Semple; J E Balow; P Gorden
Journal: J Clin Endocrinol Metab Date: 2010-05-19 Impact factor: 5.958

Review 4. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review.

Authors: Sigong Zhang; Guochun Wang; Jinping Wang
Journal: Clin Rheumatol Date: 2012-10-03 Impact factor: 2.980

10. Efficacy of oral glucocorticoid and cyclosporine in a case of rituximab-refractory type B insulin resistance syndrome.

Authors: Masahiro Takei; Hiroaki Ishii; Yuko Kawai; Kosuke Kato; Takashi Sekido; Yoshihiko Sato; Teiji Takeda; Mitsuhisa Komatsu
Journal: J Diabetes Investig Date: 2015-03-13 Impact factor: 4.232

Rituximab therapy for the type B syndrome of severe insulin resistance.

1. Paradigm shift in the management of type B insulin resistance.

2. Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.

3. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Review 4. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review.

Review 5. Type B insulin resistance developing during interferon-alpha therapy.

Review 6. Allergic reactions to human insulin: a review of current knowledge and treatment options.

Review 7. Insulin autoimmune syndrome: from diagnosis to clinical management.

8. Rituximab induced hypoglycemia in non-Hodgkin's lymphoma.

9. Successful treatment of type B insulin resistance with rituximab.

10. Efficacy of oral glucocorticoid and cyclosporine in a case of rituximab-refractory type B insulin resistance syndrome.